BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Nephrol. Dec 25, 2025; 14(4): 113300
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.113300
Table 1 Baseline characteristics of the patients

Total
PTDM
Controls
P value
Total patients723240
Male gender61 (84.7)30 (93.7)31 (77.5)0.057
Age (years), mean ± SD32.4 ± 9.234.6 ± 9.630.7 ± 8.50.076
> 4055 (76.3)34 (85.0)21 (65.0)0.092
< 4017 (23.6)6 (15.0)11 (35.0)
Dialysis vintage, months, median (minimum-maximum)17.0 (12.0-25.5)14.5 (10.0-24.5)17.0 (13.0-27.0)0.189
BMI, kg/m2, mean ± SD19.9 ± 3.820.5 ± 3.719.4 ± 3.90.266
BMI grading0.338
028 (38.8)9 (28.1)19 (47.5)
126 (36.1)19 (59.3)17 (42.5)
25 (6.9)3 (9.3)2 (5.0)
33 (4.1)1 (3.1)2 (5.0)
BMI grading at 12 months
020 (27.7)7 (21.8)13 (32.5)0.294
144 (61.1)21 (65.6)23 (57.5)
26 (8.3)4 (12.5)2 (5.0)
32 (2.7)02 (5.0)
Recipient blood cohort
O16 (22.2)7 (21.8)9 (22.5)0.371
AB5 (6.9)1 (3.1)4 (10.0)
A20 (27.0)7 (21.8)13 (32.5)
B30 (41.6)17 (53.1)13 (32.5)
Native kidney disease
Unclassified43 (59.7)16 (50.0)27 (67.5)0.714
Chronic TID13 (18.0)7 (21.8)6 (15.0)
IgA9 (12.5)5 (15.6)4 (10.0)
FSGS4 (5.5)2 (6.2)2 (5.0)
MPGN1 (1.3)1 (3.1)0
ADPKD2 (2.7)1 (3.1)1 (2.5)
Family history of DM6 (8.3)5 (15.6)1 (2.5)0.045
History of smoking2 (2.7)2 (6.2)00.113


Write to the Help Desk